In the last trading session, 0.15 million shares of the IO Biotech Inc (NASDAQ:IOBT) were traded, and its beta was 0.21. Most recently the company’s share price was $1.21, and it changed around $0.01 or 0.83% from the last close, which brings the market valuation of the company to $79.72M. IOBT currently trades at a discount to its 52-week high of $1.73, offering almost -42.98% off that amount. The share price’s 52-week low was $0.66, which indicates that the current value has risen by an impressive 45.45% since then.
IO Biotech Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended IOBT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
IO Biotech Inc (NASDAQ:IOBT) trade information
Instantly IOBT has showed a green trend with a performance of 0.83% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.2899 on recent trading dayincreased the stock’s daily price by 6.19%. The company’s shares are currently up 31.52% year-to-date, but still up 23.47% over the last five days. On the other hand, IO Biotech Inc (NASDAQ:IOBT) is 31.12% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -27.25%. IO Biotech Inc earnings are expected to increase by 2.55% in 2025, but the outlook is positive 20.37% per year for the next five years.
IOBT Dividends
IO Biotech Inc’s next quarterly earnings report is expected to be released in June.
NOVO HOLDINGS A/S, with 6.7234% or 4.43 million shares worth $5.18 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Bridgeway Funds, Inc.-Ultra-Small Company Market Fund and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 174.0 shares worth $0.21 million, making up 0.26% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund held roughly 33.31 shares worth around $40301.0, which represents about 0.05% of the total shares outstanding.
